Current Cardiac Patients News and Events | Page 25

Current Cardiac Patients News and Events, Cardiac Patients News Articles.
Sort By: Most Relevant | Most Viewed
Page 25 of 25 | 1000 Results
New drug protects heart from cardiac rupture after myocardial infarction
There are currently many kinds of drugs for heart failure. Among them, the new drug LCZ696 is recommended by US guidelines as a first-line treatment for chronic heart failure. LCZ696 is better than conventional drugs at reducing cardiac death and hospitalization due to heart failure. Now, Japanese researchers have revealed that LCZ696 can prevent cardiac rupture and heart failure following acute myocardial infarction which is one of the causes of chronic heart failure. (2017-10-02)

Study shows MRIs are safe for patients with wide variety of pacemakers, defibrillators
Magnetic resonance imaging appears to be safe for patients with cardiac implantable electronic devices, even for chest imaging, according to a new study. (2017-09-29)

Getting to the heart of mapping arrhythmia-related excitations
Atrial fibrillation is the most prevalent form of cardiac arrhythmia, affecting up to 6 million people in the US alone. Common treatments for severe forms of the erratic beating phenomenon are controversial, and guided by detection methods that are not yet standardized or fully refined. But research from a group of cross-disciplinary scientists, published this week in the journal Chaos, offers a computational approach to understanding the important factors involved in measuring cardiac excitation waves. (2017-09-29)

Study explores the biology of mending a broken heart
Early research results suggest scientists might be on to a way to preserve heart function after heart attacks or for people with inherited heart defects called congenital cardiomyopathies. Researchers at the Cincinnati Children's Heart Institute report Sept. 28 in Nature Communications that after simulating heart injury in laboratory mouse models, they stopped or slowed cardiac fibrosis, organ enlargement and preserved heart function by blocking a well-known molecular pathway. (2017-09-28)

Patients undergoing out-of-hospital cardiac arrest do not benefit from ACLS during transport
There is no association between prehospital advanced cardiac life support (ACLS) and survival to hospital discharge in patients suffering from out-of-hospital cardiac arrest. ACLS is, however, associated with an improvement in prehospital return of spontaneous circulation, but with longer delays to hospital arrival. (2017-09-25)

People are reluctant to use public defibrillators to treat cardiac arrests
A study led the University of Warwick suggests that people are reluctant to use public-access defibrillators to treat cardiac arrests. (2017-09-25)

Families of survivors of ECMO for heart conditions report favorable quality of life
One of the few large studies to report long-term outcomes in cardiac patients treated in childhood with extracorporeal membrane oxygenation (ECMO) has found overall favorable outcomes among survivors, as reported by families. ECMO provides short-term breathing and heart support for critically ill children while doctors treat the underlying illness. (2017-09-22)

Monitoring the heart's mitochondria to predict cardiac arrest?
A new device can assess in real time whether the body's tissues are receiving enough oxygen and, placed on the heart, can predict cardiac arrest in critically ill heart patients. (2017-09-20)

One e-cigarette with nicotine leads to adrenaline changes in nonsmokers' hearts
Electronic cigarettes have been touted as both a safer alternative for smokers and as an effective way for people to gradually quit smoking altogether. But a new study shows that nicotine inhaled from e-cigarettes can greatly increase a person's heart rate and aggravate the sympathetic nervous system. (2017-09-20)

The wrong first step to revive athletes in cardiac arrest
New research presented in HeartRhythm, suggests that the main obstacle to an appropriate bystander response during athletes' cardiac arrest could be an apparently widespread myth: that 'tongue swallowing' is a common complication of sudden loss of consciousness that must be avoided or relieved at all costs to prevent death from asphyxia. (2017-09-19)

Re-interventions are common in long-term survivors of childhood heart operation
Among patients who undergo childhood heart surgery for the severe birth defect single-ventricle disease, two-thirds of survivors require a surgical or catheter-based procedure within 20 years. Pediatric cardiology researchers note that doctors should counsel families about the likelihood of re-interventions. (2017-09-18)

Catheterization procedure linked to potentially long-lasting blood vessel damage
Transradial catheterization -- when a clinician inserts a long thin tube through the radial artery in the arm -- is commonly used to diagnose and treat certain heart conditions. (2017-09-18)

Metabolism switch signals end for healing hearts
Researchers have identified the process that shuts down the human heart's ability to heal itself, and are now searching for a drug to reverse it. University of Queensland's Dr James Hudson and Murdoch Children's Research Institute researcher Dr Enzo Porrello have shown a metabolic pathway governs the loss of the heart's proliferative capacity. (2017-09-18)

Poor sleep hastens progression of kidney disease
People with chronic kidney disease may be especially vulnerable to the deleterious effects of poor sleep, according to a new paper published in the Journal of the American Society of Nephrology. (2017-09-14)

Magnetic cellular 'Legos' for the regenerative medicine of the future
By incorporating magnetic nanoparticles in cells and developing a system using miniaturized magnets, researchers have succeeded in creating cellular magnetic 'Legos.' They were able to aggregate cells using only magnets and without an external supporting matrix, with the cells then forming a tissue that can be deformed at will. (2017-09-12)

Successful transcatheter treatment of severe cardiac failure, a world first
The Cardiovascular Surgery Group at Osaka University performed a transcatheter mitral valve implantation in dysfunctional artificial valves in severe cardiac failure patients with prosthetic valve dysfunction. (2017-09-11)

Novel intensive care improves treatment for heart patients -- and cuts costs
Researchers at the University of Maryland School of Medicine find that a new, collaborative treatment model for seriously ill heart patients with breathing difficulties results in better care and lower costs. (2017-09-11)

Patients to benefit from new 3-D visualizations of the heart
In the future heart surgeons will have access to a new type of 3-D visualization of the cardiac conduction system. This technique could provide improved safety for patients and improve surgical outcomes in patients suffering from heart disease and cardiac malformations, says Dr. Robert Stephenson, Aarhus University. (2017-09-11)

Study examines use of systolic blood pressure at time of primary percutaneous coronary intervention
Researchers have led a retrospective single-center study examining simple hemodynamic parameters obtained at the time of cardiac catheterization to predict in-hospital mortality following ST-elevation myocardial infarction (STEMI). Current 30-day mortality rates for patients with STEMI range from 2.5% to 10%, and 10.5%-24% of those patients require mechanical hemodynamic support. (2017-09-11)

Potentially lifesaving implantable cardioverter defibrillators underutilized in eligible patients
Fewer than 10 percent of people who experience sudden cardiac arrest outside of a hospital survive. Reoccurrence rates after an initial event are high, which is why current Canadian Cardiovascular Society, as well as other international guidelines, strongly recommend the use of implantable cardioverter defibrillators (ICDs) in selected patients who survive cardiac arrest. Despite this recommendation, a new study published in the Canadian Journal of Cardiology reveals that real-life ICD utilization rates are lower than expected. (2017-09-07)

Penn researchers closer to uncovering a new feature in heart failure
While there is a length range for classifying a healthy telomere, researchers found, for the first time ever, that people with heart failure have shorter telomeres within the cells that make up the heart muscle (known as cardiomyocytes). A team of researchers from Penn Medicine, in collaboration with the University of Connecticut, published their findings today in the Journal of the American Heart Association, building on a methods paper which was published recently in Nature Protocols. (2017-09-07)

A 'virtual heart' to simulate arrhythmia
A group of researchers from MIPT and Ghent University have proposed a mathematical model which is able to determine the factors responsible for the formation of different fibrosis patterns, which are believed to cause arrhythmia. To reproduce the formation of cardiac tissue, the researchers took a mathematical model -- one that is widely applied to study tissue growth -- and optimized it using the previously collected experimental data. (2017-09-06)

Not adhering to recommended exams for severe narrowing of the aortic valve associated with increased heart failure
Patients with asymptomatic severe aortic stenosis who did not follow recommended guidelines for regular exams had poorer survival and were more likely to be hospitalized for heart failure, according to a study published by JAMA Cardiology. (2017-09-06)

Cardiac arrests in black neighborhoods less likely to get CPR, defibrillation
Compared to people who live in predominantly white neighborhoods, those who live in predominantly black areas are much less likely to receive CPR or defibrillation from a bystander when their heart suddenly stops beating while they are at home or out in the community. (2017-08-30)

Out-of-hospital cardiac arrest treatment, outcomes varies by racial make-up of neighborhood
Individuals who experienced an out-of-hospital cardiac arrest (OHCA) in neighborhoods with higher percentages of black residents had lower rates of bystander CPR and defibrillator use and were less likely to survive compared to patients who experienced an OHCA in predominantly white neighborhoods, according to a study published by JAMA Cardiology. (2017-08-30)

'Open gym' format shortens waiting time for cardiac rehab
Changing from scheduled appointments to an 'open gym' format can reduce waiting times for cardiac rehabilitation, reports a study in the September/October issue of Journal of Cardiopulmonary Rehabilitation and Prevention. The journal is published by Wolters Kluwer. (2017-08-30)

Japanese study questions benefit of treat-to-target statin therapy (EMPATHY)
A study in Japanese patients with diabetic retinopathy has questioned the benefit of treat-to-target intensive versus standard statin therapy. The late-breaking results from the EMPATHY trial are presented today in a Hot Line LBCT Session at ESC Congress. (2017-08-29)

Ablation of atrial fibrillation improves quality of life more than drugs (CAPTAF)
Ablation of atrial fibrillation improves quality of life more than drugs, even though the reduction in atrial fibrillation burden did not differ significantly between treatments, according to late-breaking results from the CAPTAF trial presented today in a Hot Line Session at ESC Congress. (2017-08-29)

Preventing sudden death in hypertrophic cardiomyopathy: ESC guidelines (HCM-EVIDENCE)
A large study conducted across North America, Europe, the Middle East and Asia has validated the ESC recommendations for predicting and preventing sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy (HCM). (2017-08-29)

Bag-mask ventilation fails to improve on endotracheal intubation in cardiac arrest (CAAM)
Bag-mask ventilation fails to improve on endotracheal intubation in out-of-hospital cardiac arrest patients, according to late-breaking results from the CAAM trial presented today in a Hot Line LBCT Session at ESC Congress. (2017-08-28)

Sildenafil should be avoided in valve disease with residual pulmonary hypertension
Sildenafil should not be used to treat residual hypertension in patients with valvular heart disease, according to late-breaking results from the SIOVAC trial presented today in a Hot Line LBCT Session at ESC Congress. The off-label use of the drug led to worse clinical outcomes including a doubled risk of hospitalization compared to placebo. (2017-08-28)

PATHWAY-2 uncovers main cause of drug-resistant hypertension, finds old drugs work best
Salt retention is the main culprit behind drug-resistant hypertension (RHTN), with older diuretic medications being the most effective treatment, according to new results from the PATHWAY-2 study. (2017-08-28)

NIPPON follow-up: Shorter dual antiplatelet therapy stands the test of time (DAPT)
Three year follow-up of patients who received dual antiplatelet therapy (DAPT) after placement of a drug-eluting stent (DES) shows that a short course of the therapy continues to be as beneficial as a longer course. (2017-08-28)

When two is better than three: Dual antithrombotic therapy cuts bleeding risk
Clinical trial finds that dabigatran dual therapy after stenting reduced bleeding risk for patients with atrial fibrillation compared with standard triple therapy. (2017-08-27)

Automatic external defibrillators save lives in amateur sports and fitness centers
Automatic external defibrillators (AEDs) save lives in amateur sports and fitness centers, according to research presented at ESC Congress today. The 18-year study found that survival from cardiac arrest reached 93 percent in centers equipped with an AED. (2017-08-27)

Study confirms safety of rapid algorithm to rule-out and rule-in myocardial infarction
The safety and efficacy of a rapid algorithm to rule-out and rule-in myocardial infarction has been confirmed in a study presented at ESC Congress today. (2017-08-27)

Risk factor driven upstream AF therapy improves sinus rhythm (RACE 3)
Risk factor driven upstream rhythm control is effective, feasible and safe in improving maintenance of sinus rhythm in patients with early short lasting atrial fibrillation (AF) and heart failure, according to late-breaking results from the RACE 3 trial presented today in a Hot Line - LBCT Session at ESC Congress.1 The novel therapy included meticulous treatment of risk factors and change of lifestyle and was superior to conventional guideline recommended rhythm control. (2017-08-27)

Catheter ablation improves outcomes in patients with heart failure and AF (CASTLE-A)
Catheter ablation improves outcomes for patients with left ventricular dysfunction and atrial fibrillation, according to late-breaking results from the CASTLE-AF trial presented today in a Hot Line -- LBCT Session at ESC Congress.1 Patients who received catheter ablation of atrial fibrillation had lower mortality and less hospitalisation for worsening heart failure compared to those receiving conventional drug treatment. (2017-08-27)

ESC/EACTS Guidelines for the management of valvular heart disease published today
European Society of Cardiology (ESC) / European Association for Cardio-Thoracic Surgery (EACTS) Guidelines for the management of valvular heart disease are published online today in European Heart Journal1 and on the ESC website. (2017-08-26)

ESC focused update on dual antiplatelet therapy in coronary artery disease published today
The first ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease is published online today in European Heart Journal,1 and on the ESC website.2 The document was developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). (2017-08-26)

Page 25 of 25 | 1000 Results
   First   Previous   Next      Last is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to